Paradigm Biopharmaceuticals | PAR - Operating Profit

Stock Price
0.24
Daily Change
-0.01 -4.80%
Monthly
-4.80%
Yearly
-17.93%
Q2 Forecast
0.25

Paradigm Biopharmaceuticals reported AUD-21.57M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Avita Medical AUD -10.41M 742K Dec/2025
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025